Agilent Technologies (A) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $41.96B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Padraig McDonnell |
| IPO Date | 1999-11-18 | CAGR | -0.5% |
| Employees | 18,000 | Website | www.agilent.com |
| Div. Yield | 0.32% | Payout Ratio | 20% |
| Buy Back Yield | 0.59% | Total Yield | 0.91% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $37.93B | P/E | 25.57 | Forward P/E | 22.47 | PEG | 0.5 |
| P/S | 8.95 | P/B | 9.09 | P/CF | 44.63 | P/FCF | 51.5 |
| Sales | $7.23B | Sales 1Y | 9.11% | Sales 3Y | 2.73% | Sales 5Y | 24.33% |
| EPS | $5.81 | EPS 1Y | 22.96% | EPS 3Y | 9.69% | EPS 5Y | 67.11% |
| Sales QoQ | 2.06% | EPS QoQ | 12.15% | Sales QoQ Avg | 2.49% | EPS QoQ Avg | 17.27% |
| Gross Margin | 25.97% | Operating Margin | 21.5% | Profit Margin | 19.55% | ROCE | 14.4% |
| ROA | 11% | ROE | 21% | Altman Z Score | 5.04 | Piotroski Score | 8 |
| Current Ratio | 2.1 | Quick Ratio | 1.62 | Cash Ratio | 0.8 | Op. CF Ratio | 0.12 |
| Debt/Equity | 0.47 | Debt/Assets | 0.26 | Lt Debt/Equity | 0.43 | Lt Debt/Cap. | 0.3 |
| Intrst Cov. | 311 | Inventory Turnover | 3.15 | Asset Turnover | 0.55 | Receivables Turnover | 4.83 |
| Enterprise Value | $37.93B | P/E Ratio | 25.57 |
| Forward P/E | 22.47 | PEG Ratio | 0.5 |
| P/S Ratio | 8.95 | P/B Ratio | 9.09 |
| P/CF Ratio | 44.63 | P/FCF Ratio | 51.5 |
| EPS | $5.81 | EPS Growth 1Y | 22.96% |
| EPS Growth 3Y | 9.69% | EPS Growth 5Y | 67.11% |
| Revenue Growth 1Y | 9.11% | Gross Margin | 0.26% |
| Operating Margin | 0.22% | Profit Margin | 0.2% |
| ROE | 0.21% | ROA | 0.11% |
| ROCE | 0.14% | Current Ratio | 2.1 |
| Quick Ratio | 1.62 | Cash Ratio | 0.8 |
| Debt/Equity | 0.47 | Interest Coverage | 311 |
| Altman Z Score | 5.04 | Piotroski Score | 8 |
Agilent Technologies (A) valuation & financials
Agilent Technologies (A) has a market capitalization of $41.96B and trades at a price-to-earnings ratio of 25.6. It operates in the Healthcare sector (Medical - Diagnostics & Research).
Agilent Technologies's revenue grew +9.1% over the last year.
Agilent Technologies's next earnings report is scheduled for August 26, 2026 after market close; analysts estimate EPS of $1.49. Check the earnings calendar to see all companies reporting this week.
Agilent Technologies (A) — frequently asked questions
When does Agilent Technologies (A) report earnings next?
Agilent Technologies is expected to report earnings on August 26, 2026 after market close. Analysts estimate EPS of $1.49.
What is Agilent Technologies's market cap?
Agilent Technologies (A) has a market capitalization of $41.96B.
What is A's P/E ratio?
Agilent Technologies trades at a price-to-earnings ratio of 25.6, with trailing twelve-month EPS of $5.81.
How fast is Agilent Technologies growing?
Agilent Technologies's revenue grew +9.1% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)